Abstract
The haemolytic effects of a series of amphiphilic calix-arene derived Solid LipidNanoparticles (SLNs) have been measured on human erythrocytes. The effectsof both the hydrophobic chain length and the nature of the polar head-groups on theamphiphilic calix[4]arene have been investigated. For all systems, no haemolyticeffects are observed.
References
C.D. Gutsche: Calixarenes, The Royal Society of Chemistry, Cambridge (1989).
J. Szetjli: Cyclodextrin Technology, Kluwer Academic Press, Dordrecht (1988).
G.W. Gokel: Crown Ethers and Cryptands, The Royal Society of Chemistry, Cambridge (1991).
P.D. Hart, J.A. Armstrong, and E. Brodaty: Infect. Immun. 64, 1491 (1996).
E. Aubert-Foucher, D.J.S. Hulmes, and A.W. Coleman, PCT-Int WO 0007585 (2001).
G. Droogmans, J. Prenen, J. Eggermont, and T. Voets: Am. J. Physiol. 275, 646 (1998).
K.M. Hwang, Y.M. Qi, S.Y. Liu, T.C. Lee, and W. Choy: J. Chen 9403165 (1994).
Y. Hamuro, M.C. Calama, H.S. Park, and A.D. Hamilton: Angew. Chem., Int. Ed. 36, 2680 (1997).
J. de Mendoza, F. Cuevas, P. Prados, E.S. Meadows, and G.W. Gokel: Angew. Chem., Int. Ed. 37, 1534 (1998).
Y. Tanaka, Y. Kobuke, and M. Sokabe: Angew. Chem., Int. Ed. 34, 693 (1995).
P. Shahgaldian, M. Cesario, P. Goreloff, and A.W. Coleman: J. Chem. Soc., Chem. Commun. 326 (2002).
E. Houel, A. Lazar, E. Da Silva, A.W. Coleman, A. Solovyov, and S. Cherenok, and V.I. Kalchenko: Langmuir 18, 1374 (2002).
D. Duchêne, G. Ponchel, and D. Wouessidjewe: Adv. Drug Deliv. Rev. 36, 29 (1999).
T. Irie, M. Otagiri, M. Sunada, K. Uekama, Y. Ohtani, Y. Yamada, and Y. Sugiyama: J. Pharm. Dyn. 5, 741. FIELD Reference Number: FIELD Journal Code:7901854 FIELD Call Number: (1982).
E. Albers and B.W. Muller: J. Pharm. Sci. 81, 756 (1992).
F. Fauvelle, J.C. Debouzy, S. Crouzy, M. Goeschl, and Y. Chapron: J. Pharm. Sci. 86, 935 (1997).
J.C. Debouzy, F. Fauvelle, S. Crouzy, Y. Chapron, M. Goschl, and A. Gadelle: J. Pharm. Sci. 87, 59 (1998).
E. Leray, F. Leroy-Lechat, H. Parrot-Lopez, and D. Duchene: Supramol. Chem. 5, 149 (1995).
M. Bost, V. Laine, F. Pilard, A. Gadelle, J. Defaye, and B. Perly: J. Inclusion Phenom. Mol. Recogn. Chem. 29, 57 (1997).
M.H.B.G. Gansey, A.S. De Haan, E.S. Bos, W. Verboom, and D.N. Reinhoudt: Bioconjugate Chem. 10, 613 (1999).
M.H. Paclet, F. Morel, P. Shahgaldian, and A.W. Coleman: Unpublished results.
J. Gualbert, P. Shahgaldian, and A.W. Coleman: Int. J. Pharm. 257, 69 (2003).
P. Shahgaldian, J. Gualbert, and A.W. Coleman: J. Supramol. Chem. 2, 459 (2002).
P. Shahgaldian, A.W. Coleman, and V.I. Kalchenko: Tetrahedron Lett. 42, 577 (2001).
P. Shahgaldian, E. Da Silva, A.W. Coleman, B. Rather, and M.J. Zaworotko: Int. J. Pharm. 253, 23 (2003).
P. Shahgaldian and A.W. Coleman: Langmuir 19, 5261 (2003).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Shahgaldian, P., Da Silva, E. & Coleman, A.W. A First Approach to the Study of Calixarene Solid Lipid Nanoparticle (SLN) Toxicity. Journal of Inclusion Phenomena 46, 175–177 (2003). https://doi.org/10.1023/A:1026301906487
Issue Date:
DOI: https://doi.org/10.1023/A:1026301906487